The estimated Net Worth of Gert L.Volati Ltd Perlhagen is at least $136 millió dollars as of 6 May 2016. Gert Perlhagen owns over 207,386 units of NovoCure Ltd stock worth over $136,002,679 and over the last 9 years Gert sold NVCR stock worth over $0.
Gert has made over 2 trades of the NovoCure Ltd stock since 2016, according to the Form 4 filled with the SEC. Most recently Gert exercised 207,386 units of NVCR stock worth $744,516 on 6 May 2016.
The largest trade Gert's ever made was exercising 207,386 units of NovoCure Ltd stock on 6 May 2016 worth over $744,516. On average, Gert trades about 138,257 units every 0 days since 2015. As of 6 May 2016 Gert still owns at least 7,893,365 units of NovoCure Ltd stock.
You can see the complete history of Gert Perlhagen stock trades at the bottom of the page.
Over the last 9 years, insiders at NovoCure Ltd have traded over $237,132,855 worth of NovoCure Ltd stock and bought 164,174 units worth $2,198,429 . The most active insiders traders include Asaf Danziger, William Fwfd Ventures Fund ... és Michael J. Ambrogi. On average, NovoCure Ltd executives and independent directors trade stock every 7 days with the average trade being worth of $853,350. The most recent stock trade was executed by Ashley Cordova on 2 August 2024, trading 688 units of NVCR stock currently worth $13,856.
we are a commercial-stage oncology company developing a novel, proprietary therapy called tumor treating fields, or ttfields, for the treatment of solid tumor cancers. we count on the contributions of our talented team members who are committed to improving the lives of cancer patients. here at novocure, cancer patients and their families are – and have always been – at the core of our mission. we expect our colleagues to excel, and in return, we invest in their professional growth and personal well-being. we seek high performers who thrive in fast-paced environments and are inspired by making a difference in cancer care. we offer employment opportunities in the u.s., europe and asia.
NovoCure Ltd executives and other stock owners filed with the SEC include: